People at considerable risk of developing severe Covid-19, including millions of Americans with , now have the option of receiving a preventive if they have been or are at risk of being exposed to the coronavirus, reports.
Myron Cohen, MD, the聽Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, and one of the investigators behind the study of REGEN-COV as prevention, said that monoclonal antibodies protect against severe illness by overwhelming the coronavirus infection while it is still mostly in the nose and throat.
鈥淚t鈥檚 a race between your ability to make an antibody to protect your lungs and the rest of your body and the virus,鈥� he said in the article. 鈥淎nd if you鈥檙e likely to lose the race, you鈥檙e the person for whom these antibody drugs are appropriate.鈥�
.